Denali Therapeutics vs MeiraGTx
DNLI and MGTX side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How DNLI and MGTX compare
Denali Therapeutics is the larger company, worth 3.6 times as much as MeiraGTx ($3.0B against $844M).
MeiraGTx scores higher on the StockData Score (9 against 6 for Denali Therapeutics), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | DNLI | MGTX |
|---|---|---|
| Size and price | ||
| Market cap | $3.0B | $844M |
| Share price | $18.89 | $8.79 |
| Change, 1 year | 7.5% | −1.2% |
| Change, 5 years | −59.9% | −52.9% |
| Beta (5Y) | 1.66 | 1.56 |
| Employees | 503 | 403 |
| StockData Score | ||
| Total score | 6 | 9 (better) |
| Valuation score | 0 | 4 (better) |
| Growth score | 0 | 2 (better) |
| Performance score | 1 | 2 (better) |
| Health score | 5 (better) | 1 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | – | 11.0× |
| P/S | – | 2.1× |
| P/B | 3.6× | – |
| EV/EBITDA | – | 4.1× |
| FCF yield | −14.5% | −0.35% (better) |
| Fair value | – | $26.80 |
| Margin of safety | – | 67.2% |
| Growth | ||
| Revenue growth (TTM) | – | 1366% |
| Revenue growth, 5Y average | – | 39.2% |
| Profitability | ||
| Operating margin | – | 44.8% |
| Net margin | – | 19.5% |
| FCF margin | – | −0.74% |
| Return on equity | −54.9% | – |
| Return on invested capital | −343% | – |
| Financial health | ||
| Debt / equity | 0.00 | – |
| Net debt / EBITDA | – | −0.33 |
| Current ratio | 8.37 (better) | 4.62 |
| Altman Z-score | 1.96 | 2.99 (better) |
| Piotroski F-score | 3 | 4 (better) |
| Dividends and buybacks | ||
| Buyback yield | – | −20.8% |
| Shareholder yield | 0.00% (better) | −20.8% |
| Ownership | ||
| Held by institutions | 97.7% | 82.5% |
| Held by insiders | 6.6% | 35.2% |
| Insider net buying, 12 months | −$1.3M (better) | −$4.7M |
| Short interest, % of float | 9.8% | 10.7% |
Go deeper
- DNLI stock overview
- DNLI income statement
- DNLI valuation and score
- MGTX stock overview
- MGTX income statement
- MGTX valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.